Hide metadata

dc.date.accessioned2017-11-06T16:22:42Z
dc.date.available2017-11-06T16:22:42Z
dc.date.created2014-12-17T15:55:09Z
dc.date.issued2014
dc.identifier.citationWeedon-Fekjær, Harald Romundstad, Pål Richard Vatten, Lars Johan . Modern mammography screening and breast cancer mortality: Population study. BMJ (British Medical Journal). 2014, 348
dc.identifier.urihttp://hdl.handle.net/10852/59067
dc.description.abstractObjective: To evaluate the effectiveness of contemporary mammography screening using individual information about screening history and breast cancer mortality from public screening programmes. Design: Prospective cohort study of Norwegian women who were followed between 1986 and 2009. Within that period (1995-2005), a national mammography screening programme was gradually implemented, with biennial invitations sent to women aged 50-69 years. Participants: All Norwegian women aged 50-79 between 1986 and 2009. Main outcome measures: Multiple Poisson regression analysis was used to estimate breast cancer mortality rate ratios comparing women who were invited to screening (intention to screen) with women who were not invited, with a clear distinction between cases of breast cancer diagnosed before (without potential for screening effect) and after (with potential for screening effect) the first invitation for screening. We took competing causes of death into account by censoring women from further follow-up who died from other causes. Based on the observed mortality reduction combined with the all cause and breast cancer specific mortality in Norway in 2009, we used the CISNET (Cancer Intervention and Surveillance Modeling Network) Stanford simulation model to estimate how many women would need to be invited to biennial mammography screening in the age group 50-69 years to prevent one breast cancer death during their lifetime. Results: During 15 193 034 person years of observation (1986-2009), deaths from breast cancer occurred in 1175 women with a diagnosis after being invited to screening and 8996 women who had not been invited before diagnosis. After adjustment for age, birth cohort, county of residence, and national trends in deaths from breast cancer, the mortality rate ratio associated with being invited to mammography screening was 0.72 (95% confidence interval 0.64 to 0.79). To prevent one death from breast cancer, 368 (95% confidence interval 266 to 508) women would need Conclusion: Invitation to modern mammography screening may reduce deaths from breast cancer by about 28%.en_US
dc.languageEN
dc.rightsAttribution-NonCommercial 3.0 Unported
dc.rights.urihttps://creativecommons.org/licenses/by-nc/3.0/
dc.titleModern mammography screening and breast cancer mortality: Population studyen_US
dc.typeJournal articleen_US
dc.creator.authorWeedon-Fekjær, Harald
dc.creator.authorRomundstad, Pål Richard
dc.creator.authorVatten, Lars Johan
cristin.unitcode185,51,15,0
cristin.unitnameAvdeling for biostatistikk
cristin.ispublishedtrue
cristin.fulltextoriginal
cristin.qualitycode0
dc.identifier.cristin1186622
dc.identifier.bibliographiccitationinfo:ofi/fmt:kev:mtx:ctx&ctx_ver=Z39.88-2004&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.jtitle=BMJ (British Medical Journal)&rft.volume=348&rft.spage=&rft.date=2014
dc.identifier.jtitleBMJ (British Medical Journal)
dc.identifier.volume348
dc.identifier.doihttp://dx.doi.org/10.1136/bmj.g3701
dc.identifier.urnURN:NBN:no-61761
dc.type.documentTidsskriftartikkelen_US
dc.type.peerreviewedPeer reviewed
dc.source.issn0959-8146
dc.identifier.fulltextFulltext https://www.duo.uio.no/bitstream/handle/10852/59067/2/bmj.g3701.full.pdf
dc.type.versionPublishedVersion


Files in this item

Appears in the following Collection

Hide metadata

Attribution-NonCommercial 3.0 Unported
This item's license is: Attribution-NonCommercial 3.0 Unported